Zobrazeno 1 - 10
of 36
pro vyhledávání: '"James Frane"'
Autor:
Jeffrey Chaitow, Terri H. Lipman, Fabrizio De Benedetti, Ricardo Machado Xavier, Hermine I. Brunner, James Frane, Jianmei Wang, Nicolino Ruperto, Roger C. Allen, Graciela Espada, Manuela Pardeo, Rayfel Schneider, Diane E. Brown, Alberto Martini, Kamal N. Bharucha, Barry L. Myones, Valeria Gerloni, Daniel J. Lovell
Publikováno v:
Arthritis & Rheumatology. 67:840-848
Objective To investigate the impact of tocilizumab treatment on growth and growth-related laboratory parameters in patients with systemic juvenile idiopathic arthritis (JIA) enrolled in a phase III clinical trial. Methods Patients with systemic JIA a
First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report
Autor:
Barbara Lippe, Bradley A. Warady, D. Aaron Davis, Ron G. Rosenfeld, James Frane, Rita D. Swinford, John D. Mahan
Publikováno v:
Pediatric Nephrology. 25:1125-1130
A clear definition of the appropriate growth response during recombinant human growth hormone (rhGH) treatment has never been established in the pediatric chronic kidney disease (CKD) population. We present here data from Genentech's National Coopera
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 95:611-619
Short stature in children may be associated with low IGF-I despite normal stimulated GH levels and without other causes.Our objective was to assess the safety and efficacy of recombinant human IGF-I (rhIGF-I) in short children with low IGF-I levels.T
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 93:352-357
Although GH has been used to treat short stature in GH deficiency (GHD) and other conditions for more than 40 yr, criteria for satisfactorily defining targets for GH responsiveness have never been developed.The objective of this study was to present
Autor:
Thomas Maneatis, Barbara Lippe, Stephen F. Kemp, S. Butler, Kenneth M. Attie, James Frane, Joyce Kuntze
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 90:5247-5253
Context: Small clinical trials of GH treatment of idiopathic short stature (ISS) show variable efficacy. Objective: The study was an analysis of a large GH registry for efficacy and safety of GH treatment of ISS. There was also a comparison with a sp
Autor:
James Frane, Darrell M. Wilson
Publikováno v:
Growth Hormone & IGF Research. 15:21-25
True growth hormone deficiency (GHD) in childhood, while rare, has major clinical consequences. GHD is often associated with other pituitary hormone deficiencies, so these children may require multiple hormonal replacement and close clinical follow-u
Aim A recent secular trend towards earlier thelarche has been suggested. The aim of this study is to examine normative ages of thelarche and menarche in contemporary US females. Methods Trained physicians documented Tanner breast stage by observation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6a0c36e6ef9d99cb2d7fea80fda24b
https://europepmc.org/articles/PMC4137967/
https://europepmc.org/articles/PMC4137967/
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:2439-2445
Clinical trials of recombinant human GH therapy in Turner syndrome that began more than a decade ago show that GH accelerates the linear growth rate. Several studies indicate that final height is also improved, although the magnitude of the increase
Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 85:2439-2445
Clinical trials of recombinant human GH therapy in Turner syndrome that began more than a decade ago show that GH accelerates the linear growth rate. Several studies indicate that final height is also improved, although the magnitude of the increase
Autor:
Eileen D. Brewer, David R. Powell, Ronald J. Hogg, Susan K. Durham, Subburaman Mohan, Sandra L. Watkins, James Frane
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 84:596-601